BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 5286440)

  • 1. Erythrocyte sensitivity to in-vitro lysis in leukaemia.
    Catovsky D; Lewis SM; Sherman D
    Br J Haematol; 1971 Nov; 21(5):541-50. PubMed ID: 5286440
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of "virus-like" particles in the plasmas of 255 patients with leukemia and related diseases.
    Newell GR; Harris WW; Bowman KO; Boone CW; Anderson NG
    N Engl J Med; 1968 May; 278(22):1185-91. PubMed ID: 4172474
    [No Abstract]   [Full Text] [Related]  

  • 3. The content of erythrocyte 2,3 diphosphoglycerate and adenosine-5'-triphosphate in myelomatosis and leukaemia.
    Hjelm M; Udén AM; Engstedt L
    Scand J Haematol; 1976 Jan; 16(1):48-55. PubMed ID: 1082630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modern concepts concerning the pathogenesis of anemia in leukemia].
    Kanaev SV
    Ter Arkh; 1971 May; 43(5):8-22. PubMed ID: 4940656
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum vitamin B 12 and vitamin B 12 binding capacity in chronic myelogenous leukemia and other disorders.
    Rosner F; Schreiber ZA
    Am J Med Sci; 1972 Jun; 263(6):473-80. PubMed ID: 4505888
    [No Abstract]   [Full Text] [Related]  

  • 6. A serum haemolytic factor demonstrable at low ionic strength.
    Riedler GF; Straub PW
    Br J Haematol; 1974 May; 27(1):183-93. PubMed ID: 4527620
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of high concentrations of leukocytes on whole blood viscosity.
    Steinberg MH; Charm SE
    Blood; 1971 Sep; 38(3):299-301. PubMed ID: 5289281
    [No Abstract]   [Full Text] [Related]  

  • 8. Leukocyte antigen-antibody reaction and lysis of paroxysmal nocturnal hemoglobinuria erythrocytes.
    Sirchia G; Ferrone S; Mercuriali F
    Blood; 1970 Sep; 36(3):334-6. PubMed ID: 5311198
    [No Abstract]   [Full Text] [Related]  

  • 9. [HL-A antigens and malignant hematological diseases].
    Jeannet M; Alberto P; Wyss M
    Schweiz Med Wochenschr; 1971 Dec; 101(49):1798-800. PubMed ID: 5291103
    [No Abstract]   [Full Text] [Related]  

  • 10. [Behavior of adenosine and adenosine triphosphatase phosphoric esters in systemic histiocytic sarcomatoses].
    Mandelli F; Fontana L; Papa G; De Laurenzi A
    Riv Emoter Immunoematol; 1967; 14(5):221-44. PubMed ID: 4244545
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cytochemical study of lactic acid in leukemia cells].
    Piette M; Durand G
    Nouv Rev Fr Hematol; 1969; 9(5):688-96. PubMed ID: 4313092
    [No Abstract]   [Full Text] [Related]  

  • 12. [Behavior of various erythrocyte enzymes of the anaerobic glycolytic pathway in systemic histocytic sarcomatoses].
    De Laurenzi A; Fontana L; Papa G
    Riv Emoter Immunoematol; 1967; 14(5):197-219. PubMed ID: 5264421
    [No Abstract]   [Full Text] [Related]  

  • 13. [The osmotic stability, glucose-6-phosphate dehydrogenase and glutathione reductase activity of the erythrocytes of leukemia and anemia patients].
    Luganova IS; Seĭts IF
    Biull Eksp Biol Med; 1968 Aug; 66(8):97-9. PubMed ID: 5273790
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum ferritin levels in hematologic malignant neoplasms.
    Patel AR; Shah PC; Vohra RM; Hart WL; Shah JR
    Arch Pathol Lab Med; 1980 Oct; 104(10):509-12. PubMed ID: 6932189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute leukemia as a terminal event in nonleukemic hematopoietic disorders.
    Bloomfield CD; Brunning RD
    Semin Oncol; 1976 Sep; 3(3):297-317. PubMed ID: 790581
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphocytotoxins in leukaemia.
    Dickson A
    Br Med J; 1972 Oct; 4(5834):209-11. PubMed ID: 4507754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic usefulness of acridine orange in fluorescence microscopy in certain hematological syndromes, particularly in proliferative processes.
    Topolska P; Gürtler-Krawczyńska E
    Pol Med J; 1968; 7(2):372-9. PubMed ID: 5241714
    [No Abstract]   [Full Text] [Related]  

  • 18. [Metabolism of blood leukocytes in patients with malignant hemopathies and hematosarcomas during the course of chemotherapy].
    Lille I; Gabay P; Clavel B; Saracino RT; Bourdin JS
    Nouv Rev Fr Hematol; 1969; 9(5):715-21. PubMed ID: 4244273
    [No Abstract]   [Full Text] [Related]  

  • 19. Tissue culture of bone marrow. 3. Myelostimulatory factors in serum of patients with myeloproliferative diseases.
    Reisner EH
    Cancer; 1967 Oct; 20(10):1679-88. PubMed ID: 5234302
    [No Abstract]   [Full Text] [Related]  

  • 20. [Osmotic fragility in subfractions of leucocytes in hematological diseases (author's transl)].
    Benöhr HC; Nerke O; Waller HD
    Blut; 1979 Dec; 39(6):393-7. PubMed ID: 293198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.